NO913232D0 - Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse. - Google Patents

Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.

Info

Publication number
NO913232D0
NO913232D0 NO913232A NO913232A NO913232D0 NO 913232 D0 NO913232 D0 NO 913232D0 NO 913232 A NO913232 A NO 913232A NO 913232 A NO913232 A NO 913232A NO 913232 D0 NO913232 D0 NO 913232D0
Authority
NO
Norway
Prior art keywords
analogs
production
pdgf
present
growth factor
Prior art date
Application number
NO913232A
Other languages
English (en)
Other versions
NO913232L (no
Inventor
Arlen Read Thomason
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/454,794 external-priority patent/US5149792A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO913232D0 publication Critical patent/NO913232D0/no
Publication of NO913232L publication Critical patent/NO913232L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO91913232A 1989-12-19 1991-08-19 Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse. NO913232L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/454,794 US5149792A (en) 1989-12-19 1989-12-19 Platelet-derived growth factor B chain analogs
US07/624,451 US5272064A (en) 1989-12-19 1990-12-13 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
PCT/US1990/007451 WO1991008761A1 (en) 1989-12-19 1990-12-17 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof

Publications (2)

Publication Number Publication Date
NO913232D0 true NO913232D0 (no) 1991-08-19
NO913232L NO913232L (no) 1991-08-19

Family

ID=27037609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913232A NO913232L (no) 1989-12-19 1991-08-19 Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.

Country Status (17)

Country Link
US (1) US5272064A (no)
EP (1) EP0458959B1 (no)
JP (1) JPH04504064A (no)
AT (1) ATE123949T1 (no)
AU (1) AU646014B2 (no)
CA (1) CA2032675A1 (no)
DE (1) DE69020335T2 (no)
DK (1) DK0458959T3 (no)
ES (1) ES2073735T3 (no)
FI (1) FI913892A0 (no)
GR (1) GR3017317T3 (no)
IE (1) IE904608A1 (no)
IL (1) IL96723A0 (no)
NO (1) NO913232L (no)
NZ (1) NZ236549A (no)
PT (1) PT96272A (no)
WO (1) WO1991008761A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU670075B2 (en) * 1992-02-26 1996-07-04 Allergan, Inc. Use of platelet derived growth factor in ophthalmic wound healing
ZA932179B (en) * 1992-03-30 1994-09-26 Schering Corp Monomeric platelet-derived growth factor and prevention of stenosis or restenosis
US6872549B2 (en) 2002-03-27 2005-03-29 Immunex Corporation Methods for increasing polypeptide production
US20040248796A1 (en) * 2003-02-04 2004-12-09 Kari Alitalo VEGF-B and PDGF modulation of stem cells
EP2454368A4 (en) 2009-07-17 2013-01-09 Aaron Thomas Tabor COMPOSITIONS AND METHOD FOR THE GENETIC MODIFICATION OF COSMETIC FUNCTION CELLS FOR IMPROVING THE COSMETIC APPEARANCE PICTURE
EP2601287B1 (en) 2010-08-05 2015-01-07 Amgen Inc. Dipeptides to enhance yield and viability from cell cultures
EP2699293B8 (en) 2011-04-20 2022-07-20 Amgen Inc. Autoinjector apparatus
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
DK2726600T3 (en) 2011-07-01 2017-05-15 Amgen Inc Mammalian Cell Culture
AU2012301656A1 (en) 2011-09-02 2014-01-16 Amgen Inc. Pharmaceutical product and method of analysing light exposure of a pharmaceutical product
AR089231A1 (es) 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
US20150353542A1 (en) 2013-01-14 2015-12-10 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
TWI771890B (zh) 2013-03-14 2022-07-21 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
EP3395423B1 (en) 2013-03-14 2023-09-20 Amgen Inc. Removal of leaked affinity purification ligand
EP2968760B1 (en) 2013-03-15 2024-01-03 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
CA2904661C (en) 2013-03-15 2022-03-15 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
SG11201507417RA (en) 2013-03-15 2015-10-29 Amgen Inc Body contour adaptable autoinjector device
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
HUE071397T2 (hu) 2013-10-31 2025-08-28 Amgen Inc Monenzin alkalmazása rekombináns fehérjék glikozilációjának szabályozására
EP3094735A1 (en) 2014-01-13 2016-11-23 Amgen Inc. Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins
JP6474420B2 (ja) 2014-01-29 2019-02-27 アムジエン・インコーポレーテツド 組換えタンパク質のグリコシル化を調節するためのｎ−グリコシル化経路制御因子の過剰発現
US10106829B2 (en) 2014-01-29 2018-10-23 Amgen Inc. Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
PT3152317T (pt) 2014-06-04 2019-04-18 Amgen Inc Métodos de colheita de culturas de células de mamíferos
ES2727380T3 (es) 2014-11-19 2019-10-15 Amgen Inc Cuantificación de resto glucano en glucoproteínas recombinantes
ES2784503T3 (es) 2014-12-01 2020-09-28 Amgen Inc Procedimiento para manipular el nivel de contenido de glicano de una glicoproteína
EP3710089A1 (en) 2017-11-16 2020-09-23 Amgen Inc. Autoinjector with stall and end point detection
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
KR20220129006A (ko) 2020-01-15 2022-09-22 우시 바이올로직스 아일랜드 리미티드 배양 세포로부터 생산된 생체 물질을 연속적으로 수확하기 위한 장치 및 방법
WO2023079058A1 (en) 2021-11-05 2023-05-11 Yokogawa Insilico Biotechnology Gmbh Cell culture with reduced production of lactate
KR20240128067A (ko) 2021-12-29 2024-08-23 브리스톨-마이어스 스큅 컴퍼니 랜딩 패드 세포주의 생성

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0487116B1 (en) * 1984-10-12 1999-12-29 ZymoGenetics, Inc. Biologically active PDGF analogs in eucaryotic cells
US4769328A (en) * 1984-10-12 1988-09-06 Zymogenetics Inc. Expression of biologically active PDGF analogs in yeast
EP0259632B1 (en) * 1986-08-13 1995-12-13 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
DE3834079A1 (de) * 1988-10-06 1990-04-12 Biotechnolog Forschung Gmbh Wachstumstimulierendes pdgf-bb und dessen verwendung sowie ein verfahren zu seiner herstellung und der des monomeren
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems

Also Published As

Publication number Publication date
CA2032675A1 (en) 1991-06-20
IL96723A0 (en) 1991-09-16
ATE123949T1 (de) 1995-07-15
EP0458959A1 (en) 1991-12-04
AU7153491A (en) 1991-07-18
US5272064A (en) 1993-12-21
AU646014B2 (en) 1994-02-03
JPH04504064A (ja) 1992-07-23
WO1991008761A1 (en) 1991-06-27
NO913232L (no) 1991-08-19
FI913892A7 (fi) 1991-08-16
EP0458959B1 (en) 1995-06-21
DE69020335D1 (de) 1995-07-27
NZ236549A (en) 1993-03-26
PT96272A (pt) 1991-09-30
EP0458959A4 (en) 1993-06-16
GR3017317T3 (en) 1995-12-31
ES2073735T3 (es) 1995-08-16
DE69020335T2 (de) 1995-11-02
IE904608A1 (en) 1991-06-19
DK0458959T3 (da) 1995-08-14
FI913892A0 (fi) 1991-08-16

Similar Documents

Publication Publication Date Title
NO913232D0 (no) Nye blodplatederiverte vekstfaktor-b-kjedeanaloger og metode for homogen produksjon av disse.
Heldin et al. Chemical and biological properties of a growth factor from human‐cultured osteosarcoma cells: Resemblance with platelet‐derived growth factor
Waterfield et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus
KR880007734A (ko) 폴리펩타이드 유도체
Burgess et al. Two forms of murine epidermal growth factor: rapid separation by using reverse-phase HPLC.
KR880701105A (ko) 신규 응혈촉진 단백질
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
LU90408I2 (fr) Regranex-becaplermin
ATE91722T1 (de) Pferde-gamma-interferon.
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
DE3852706D1 (de) Verfahren zur Herstellung eines physiologisch aktiven Peptids mit einem Cysteinrest.
AU7681687A (en) Expression of platelet-derived growth factor and analogues
ATE103931T1 (de) Polypeptide aus vipergift und deren genexpression.
Proost et al. Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines
PT100651A (pt) Muteinas da interleucina 6 (il-6) isentas de cisteina
JPS6420095A (en) Polypeptide having anti-blood coagulating action
CAPONY et al. Parvalbumin from rabbit muscle: isolation and primary structure
PAN et al. Structural characterization of human interferon γ Heterogeneity of the carboxyl terminus
EP0072541A3 (en) Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
KR880701073A (ko) 제조합 dna 기법에 의해 생성된 민악티빈
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
SE8502430D0 (sv) A cdna molecule coding for the expression of an interferon alfa type polypeptide, a bacterial or cellular host transformed with such molecule and a polypeptide showing interferon activity prepared by such host
JPS6437291A (en) Human cytochrome c gene and use thereof
JPS642583A (en) Recombinant dna and production of polypeptide using said dna